These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37500359)

  • 21. Voice Tremor in Parkinson's Disease: An Acoustic Study.
    Gillivan-Murphy P; Miller N; Carding P
    J Voice; 2019 Jul; 33(4):526-535. PubMed ID: 29395332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acoustic analysis of prosody in females with Parkinson's disease: comparison with normal controls].
    Azevedo LL; Cardoso F; Reis C
    Arq Neuropsiquiatr; 2003 Dec; 61(4):999-1003. PubMed ID: 14762606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The correlation of non-motor symptoms and sleep on balance in Parkinson's disease patients with normal cognition and mild cognitive impairment.
    Saricaoglu M; Yilmaz NH; Ozer FF; Hanoglu L
    Ir J Med Sci; 2021 Nov; 190(4):1577-1584. PubMed ID: 33449322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of the measures of cepstral peak prominence as a measure of dysphonia severity in Spanish-speaking subjects.
    Núñez-Batalla F; Cartón-Corona N; Vasile G; García-Cabo P; Fernández-Vañes L; Llorente-Pendás JL
    Acta Otorrinolaringol Esp (Engl Ed); 2019; 70(4):222-228. PubMed ID: 30097163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigating the cepstral acoustic characteristics of voice in healthy children.
    Demirci AN; Köse A; Aydinli FE; İncebay Ö; Yilmaz T
    Int J Pediatr Otorhinolaryngol; 2021 Sep; 148():110815. PubMed ID: 34217000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease.
    Goldman JG; Holden S; Bernard B; Ouyang B; Goetz CG; Stebbins GT
    Mov Disord; 2013 Dec; 28(14):1972-9. PubMed ID: 24123267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Speech Characteristics of Patients with Parkinson's Disease-Does Dopaminergic Medications Have a Role?
    Vandana VP; Darshini JK; Vikram VH; Nitish K; Kumar PP; Ravi Y
    J Neurosci Rural Pract; 2021 Oct; 12(4):673-679. PubMed ID: 34737501
    [No Abstract]   [Full Text] [Related]  

  • 28. Cepstral analysis in patients with a vocal fold motility impairment: advantages of the cepstrum over time-based acoustic analysis.
    Delgado-Vargas B; Acle-Cervera L; Sánz-López L; Bonet-Loscertales M; Pérez-Naranjo N; Fuentes-Navajo P
    Eur Arch Otorhinolaryngol; 2021 Jan; 278(1):173-179. PubMed ID: 32839861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vocal Acoustics and Aerodynamics During Scripted Reading Compared to Spontaneous Speech.
    Gilman M; Shelly S; Gillespie AI
    J Voice; 2023 Jul; 37(4):539-545. PubMed ID: 34175170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment.
    Noh SW; Han YH; Mun CW; Chung EJ; Kim EG; Ji KH; Seo JH; Kim SJ
    J Neurol Sci; 2014 Dec; 347(1-2):210-3. PubMed ID: 25451006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Narrative analysis in individuals with Parkinson's disease following intensive voice treatment: secondary outcome variables from a randomized controlled trial.
    Ramage AE; Greenslade KJ; Cote K; Lee JN; Fox CM; Halpern A; Ramig LO
    Front Hum Neurosci; 2024; 18():1394948. PubMed ID: 38841124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural changes in the retina and serum HMGB1 levels are associated with decreased cognitive function in patients with Parkinson's disease.
    Liang K; Li X; Guo Q; Ma J; Yang H; Fan Y; Yang D; Shi X; She Z; Qi X; Gu Q; Chen S; Zheng J; Li D
    Neurobiol Dis; 2024 Jan; 190():106379. PubMed ID: 38104911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship of cepstral analysis with voice self-assessments in dysphonic and normal speakers.
    Saeedi S; Aghajanzadeh M; Khoddami SM; Dabirmoghaddam P; Jalaie S
    Eur Arch Otorhinolaryngol; 2023 Apr; 280(4):1803-1813. PubMed ID: 36229669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effects of Reading Speed on Acoustic Voice Parameters and Self-reported Vocal Fatigue in Students.
    Nudelman C; Webster J; Bottalico P
    J Voice; 2024 Jan; 38(1):243.e1-243.e10. PubMed ID: 34272142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fist-Edge-Palm (FEP) test has a high sensitivity in differentiating dementia from normal cognition in Parkinson's disease.
    Liu Y; Qiu MY; Zhang YL; Zhang XJ; Truong D; Tan EK; Wu YC
    J Neurol Sci; 2021 Oct; 429():118060. PubMed ID: 34479167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship Between Voice and Motor Disabilities of Parkinson's Disease.
    Majdinasab F; Karkheiran S; Soltani M; Moradi N; Shahidi G
    J Voice; 2016 Nov; 30(6):768.e17-768.e22. PubMed ID: 26725551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immediate and long-term effects of speech treatment targets and intensive dosage on Parkinson's disease dysphonia and the speech motor network: Randomized controlled trial.
    Narayana S; Franklin C; Peterson E; Hunter EJ; Robin DA; Halpern A; Spielman J; Fox PT; Ramig LO
    Hum Brain Mapp; 2022 May; 43(7):2328-2347. PubMed ID: 35141971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acoustic characteristics in relation to intelligibility reduction in noise for speakers with Parkinson's disease.
    Chiu Y; Neel A; Loux T
    Clin Linguist Phon; 2021 Mar; 35(3):222-236. PubMed ID: 32539544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Characterization of Parkinson's Disease Patients With Cognitive Impairment.
    Simon-Gozalbo A; Rodriguez-Blazquez C; Forjaz MJ; Martinez-Martin P
    Front Neurol; 2020; 11():731. PubMed ID: 32849203
    [No Abstract]   [Full Text] [Related]  

  • 40. A task-specific cognitive domain decline is correlated with plasma and neuroimaging markers in patients with Parkinson's disease.
    Li CH; Chen TF; Peng PL; Lin CH
    J Neurol; 2022 Dec; 269(12):6530-6543. PubMed ID: 35965282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.